KeraNetics, Inc., Winston-Salem, North Carolina, USA.
12279Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211039681. doi: 10.1177/15330338211039681.
Ionizing radiation causes injury to the skin that produces a complex clinical presentation that is managed by various paradigms without clear standards. The situation is further complicated by the fact that clinicians and researchers often use different terms and billing codes to describe the spectrum of cutaneous injury. There is, however, general agreement between the two most commonly-used diagnostic scales, the Radiation Therapy Oncology Group and the Common Terminology Criteria for Adverse Events, and in their use to describe skin injury following radiation therapy. These scales are typically used by radiation oncologists to quantify radiation dermatitis, a component of the radiation-related disorders of the skin and subcutaneous tissue family of diagnoses. In rare cases, patients with severe injury may require treatment by wound care or burn specialists, in which case the disease is described as a "radiation burn" and coded as a burn or corrosion. Further compounding the issue, most US government agencies use the term Cutaneous Radiation Injury to indicate skin damage resulting from large, whole-body exposures. In contrast, the US Food and Drug Administration approves products for radiation dermatitis or "burns caused by radiation oncology procedures." A review of the literature and comparison of clinical presentations shows that each of these terms represents a similar injury, and can be used interchangeably. Herein we provide a comparative review of the commonly used terminology for radiation-induced skin injury. Further, we recommend standardization across clinicians, providers, and researchers involved in the diagnosis, care, and investigation of radiation-induced skin injury. This will facilitate collaboration and broader inclusion criteria for grant-research and clinical trials and will assist in assessing therapeutic options particularly relevant to patient skin pigmentation response differences.
电离辐射会对皮肤造成损伤,产生复杂的临床表现,这些表现由各种模式进行管理,但缺乏明确的标准。由于临床医生和研究人员经常使用不同的术语和计费代码来描述皮肤损伤的范围,情况变得更加复杂。然而,在最常用的两种诊断量表——放射治疗肿瘤学组和常见不良事件术语标准之间,以及在用于描述放射治疗后皮肤损伤方面,存在着普遍的共识。这些量表通常由放射肿瘤学家用于量化放射性皮炎,这是皮肤和皮下组织放射相关疾病家族的一个组成部分。在极少数情况下,严重损伤的患者可能需要伤口护理或烧伤专家的治疗,在这种情况下,疾病被描述为“放射性烧伤”,并编码为烧伤或腐蚀。使问题进一步复杂化的是,大多数美国政府机构使用术语“皮肤放射性损伤”来表示由全身大剂量暴露引起的皮肤损伤。相比之下,美国食品和药物管理局批准用于治疗放射性皮炎或“放射肿瘤学程序引起的烧伤”的产品。对文献的回顾和临床表现的比较表明,这些术语中的每一个都代表了类似的损伤,可以互换使用。在此,我们对用于描述放射性皮肤损伤的常用术语进行了比较性回顾。此外,我们建议参与诊断、护理和研究放射性皮肤损伤的临床医生、提供者和研究人员之间实现标准化。这将促进合作,并为拨款研究和临床试验提供更广泛的纳入标准,同时还将有助于评估特别是与患者皮肤色素沉着反应差异相关的治疗选择。